Semaglutide ZPHC 10mg - 20mg (SALE OUT!)
180.00
Product Description
Semaglutide is a GLP-1 receptor agonist studied and used in specific approved medicines for blood sugar management and weight management. It acts on GLP-1 receptors involved in appetite regulation and glucose control, and can slow gastric emptying. These effects may influence feelings of fullness and food intake.
This product is supplied as lyophilized powder in five vials containing 2mg each, for a total of 10mg per box. It is not a pre-filled pen or a ready-to-use injection device.
Research Titration Reference
The following schedule is included as a research reference only and is not instructions for personal use:
-
Weeks 1–4: 0.25mg once weekly
-
Weeks 5–8: 0.5mg once weekly
-
Subsequent escalation: 1mg once weekly, if tolerated, in accordance with an approved protocol
Dosing schedules depend on the specific approved medicine, indication and individual circumstances. Do not use this schedule to self-administer an unapproved or research-only vial product.
Precautions
-
Use only approved semaglutide medicines under qualified medical supervision.
-
Potential adverse effects include nausea, vomiting, diarrhea, constipation and abdominal discomfort.
-
Semaglutide may not be appropriate for everyone; contraindications and warnings depend on the specific product and local prescribing information.
-
Do not assume sterility, purity or suitability for injection without reliable product-quality verification.
-
Follow the applicable product labeling for storage and handling. Do not assume that instructions for an approved pre-filled pen apply to this powder formulation.
For research use only: Not intended for human or veterinary use.
